SCHEMBL10150657

SCHEMBL10150657

CCCCOc1ccc2c(CC(N)=O)c[nH]c2c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ICMT O60725 4/20 0.54
HTR1B P28222 10/20 0.51
HTR1A P08908 9/20 0.51
HTR1D P28221 8/20 0.51
MAPT P10636 2/20 0.50
MAPK1 P28482 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
HTR2A P28223 2/20 0.50
KDM4E B2RXH2 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
GPR17 Q13304 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8180904 0.88 KDM4E (0.56) HTR1BHTR1AHTR1DMAPTMAPK1
SCHEMBL8171524 0.85 PKM (0.61) HTR1BHTR1AHTR1DMAPTMAPK1
SCHEMBL4854372 0.84 HTR2A (0.63) ICMTMAPTMAPK1HTR2AKDM4E
SCHEMBL2542080 0.80 HTR1A (0.76) HTR1BHTR1AHTR1DMAPTMAPK1
SCHEMBL9950019 0.80 ALDH1A1 (0.62) ICMTHTR1DMAPTKDM4EMEN1
SCHEMBL12721122 0.78 KDM4E (0.71) HTR1BHTR1AHTR1DMAPTMAPK1
SCHEMBL15678386 0.77 HTR1B (0.57) HTR1BHTR1AHTR1DMAPTMAPK1
SCHEMBL17034508 0.77 HTT (0.53) HTR1BMAPT
SCHEMBL10123846 0.76 ICMT (0.66) ICMTHTR1DMAPTHTR2ANPSR1
SCHEMBL18103513 0.76 HTR1B (0.50) HTR1BHTR1AHTR1DMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655372-B1 PYRROLOQUINOLINYL-PYRROLIDINE-2,5-DIONE COMPOSITIONS AND METHODS FOR PREPARING AND USING SAME ARQULE INC (US) 2016-03-16 EP disclosed
US-8470786-B2 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same ARQULE, INC. (US) 2013-06-25 US disclosed
US-20120165278-A1 Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions And Methods For Preparing And Using Same ARQULE, INC. (US) 2012-06-28 US disclosed
WO-2012088491-A2 PYRROLOQUINOLINYL-PYRROLIDINE-2,5-DIONE COMPOSITIONS AND METHODS FOR PREPARING AND USING SAME ARQULE, INC. (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165278-A1 Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions And Methods For Preparing And Using Same DHPS, PDCD5, DPYD ICMT 3059/4885HTR1B 3329/4885HTR1A 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.